{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:20:27Z","timestamp":1790335227385,"version":"4.1.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.vaccine.2010.07.085","type":"journal-article","created":{"date-parts":[[2010,8,8]],"date-time":"2010-08-08T04:37:25Z","timestamp":1281242245000},"page":"6698-6703","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Safety and immunogenicity of the malaria vaccine candidate GMZ2 in malaria-exposed, adult individuals from Lambar\u00e9n\u00e9, Gabon"],"prefix":"10.1016","volume":"28","author":[{"given":"Benjamin","family":"Mordm\u00fcller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Szywon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Greutelaers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meral","family":"Esen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovic","family":"Mewono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Treut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymund E.","family":"M\u00fcrbeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roma","family":"Chilengi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramadhani","family":"Noor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen L.","family":"Kilama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egeruan Babatunde","family":"Imoukhuede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Imbault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"Leroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Theisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren","family":"Jepsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Milligan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Fendel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Kremsner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saadou","family":"Issifou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2010.07.085_bib0005","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1365-3156.2009.02287.x","article-title":"From malaria control to eradication: the WHO perspective","volume":"7","author":"Mendis","year":"2009","journal-title":"Trop Med Int Health"},{"issue":"Suppl.","key":"10.1016\/j.vaccine.2010.07.085_bib0010","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1186\/1475-2875-7-S1-S10","article-title":"Malaria vaccines and their potential role in the elimination of malaria","volume":"1","author":"Targett","year":"2008","journal-title":"Malar J"},{"key":"10.1016\/j.vaccine.2010.07.085_bib0015","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2174\/156652406776055122","article-title":"Malarial parasites vs. antimalarials: never-ending rumble in the jungle","volume":"2","author":"Mordm\u00fcller","year":"2006","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.vaccine.2010.07.085_bib0020","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-4017(01)00430-7","article-title":"Parasite vaccines\u2014a reality?","volume":"1\u20133","author":"Dalton","year":"2001","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2010.07.085_bib0025","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S0140-6736(04)17223-1","article-title":"Efficacy of the RTS, S\/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial","volume":"9443","author":"Alonso","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2010.07.085_bib0030","doi-asserted-by":"crossref","first-page":"e2636","DOI":"10.1371\/journal.pone.0002636","article-title":"Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51","volume":"7","author":"Wu","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2010.07.085_bib0035","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4269\/ajtmh.1991.45.297","article-title":"Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria","volume":"3","author":"Sabchareon","year":"1991","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2010.07.085_bib0040","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1128\/IAI.66.1.11-17.1998","article-title":"The glutamate-rich protein (GLURP) of Plasmodium falciparum is a target for antibody-dependent monocyte-mediated inhibition of parasite growth in vitro","volume":"1","author":"Theisen","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2010.07.085_bib0045","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1182\/blood.V84.5.1594.1594","article-title":"Merozoite surface protein-3: a malaria protein inducing antibodies that promote Plasmodium falciparum killing by cooperation with blood monocytes","volume":"5","author":"Oeuvray","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2010.07.085_bib0050","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1128\/IAI.72.1.247-252.2004","article-title":"Association between protection against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendemicity in Myanmar: complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich protein","volume":"1","author":"Soe","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2010.07.085_bib0055","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.0141-9838.2004.00705.x","article-title":"Natural antibody response to Plasmodium falciparum Exp-1, MSP-3 and GLURP long synthetic peptides and association with protection","volume":"6\u20137","author":"Meraldi","year":"2004","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2010.07.085_bib0060","first-page":"242","article-title":"Immunization of Saimiri sciureus monkeys with a recombinant hybrid protein derived from the Plasmodium falciparum antigen glutamate-rich protein and merozoite surface protein 3 can induce partial protection with Freund and Montanide ISA720 adjuvants","volume":"2","author":"Carvalho","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2010.07.085_bib0065","doi-asserted-by":"crossref","first-page":"6862","DOI":"10.1016\/j.vaccine.2009.09.011","article-title":"Safety and immunogenicity of GMZ2\u2014a MSP3-GLURP fusion protein malaria vaccine candidate","volume":"49","author":"Esen","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.07.085_bib0070","first-page":"77","article-title":"Malaria epidemiology in the province of Moyen Ogoov, Gabon","volume":"2","author":"Wildling","year":"1995","journal-title":"Trop Med Parasitol"},{"key":"10.1016\/j.vaccine.2010.07.085_bib0075","doi-asserted-by":"crossref","first-page":"599","DOI":"10.4269\/ajtmh.2001.65.599","article-title":"Comparison of methods for the rapid laboratory assessment of children with malaria","volume":"5","author":"Planche","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2010.07.085_bib0080","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1126\/science.1076071","article-title":"Maintenance of serological memory by polyclonal activation of human memory B cells","volume":"5601","author":"Bernasconi","year":"2002","journal-title":"Science"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10011072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10011072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:17:37Z","timestamp":1759400257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10011072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":16,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0264410X10011072"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.07.085","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and immunogenicity of the malaria vaccine candidate GMZ2 in malaria-exposed, adult individuals from Lambar\u00e9n\u00e9, Gabon","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.07.085","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}